Bio-Rad and Australian Proteome Analysis Facility renew strategic collaboration
Partners to continue longstanding relationship, develop new technology to support proteomics research
"This partnership combines the strength, knowledge and expertise of leading proteomics innovators to provide scientists with access to advanced technology for protein identification," said Bio-Rad Vice President and Group Manager of Life Science, Brad Crutchfield.
"APAF is excited about this new collaboration with Bio-Rad as it aims to develop novel products that break the current bottlenecks associated with proteomics workflows," said Professor Mark Baker, APAF's newly appointed Director. "New developments will lead to quantum leaps in the depth of the discovery afforded by existing proteomic array technologies."
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.